Cimpress (CMPR) Liabilities and Shareholders Equity (2010 - 2026)
Cimpress (CMPR) posted quarterly Liabilities and Shareholders Equity of $2.1 billion for Q1 2026, up 9.4% year-over-year from $1.9 billion in Q1 2025, and down 1.88% quarter-over-quarter from $2.1 billion in Q4 2025.
Cimpress (CMPR) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Cimpress' Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $2.1 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 9.4% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $8.1 billion (up 6.76% YoY), while the FY2025 annual figure was $2.0 billion, up 4.02% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $2.1 billion, down from $2.1 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $2.2 billion in Q2 2022, with the low at $1.8 billion in Q1 2024.
- The 5-year median for Liabilities and Shareholders Equity is $1.9 billion (2023), against an average of $2.0 billion.
- The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity advanced 19.08% in 2022, then decreased 14.43% in 2023.
- Cimpress' Liabilities and Shareholders Equity stood at $2.0 billion in 2022, then fell by 0.21% to $1.9 billion in 2023, then decreased by 1.54% to $1.9 billion in 2024, then rose by 9.2% to $2.1 billion in 2025, then fell by 1.88% to $2.1 billion in 2026.
- Business Quant data shows CMPR's Liabilities and Shareholders Equity at $2.1 billion in Q1 2026, $2.1 billion in Q4 2025, and $2.0 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Cintas | 81.84 Bn | 81.56 Bn | 1.48 Bn | 10.53 Bn |
| 2 | Relx | 65.92 Bn | 65.74 Bn | - | 19.63 Bn |
| 3 | Copart | 31.68 Bn | 28.33 Bn | 732.88 Mn | 9.65 Bn |
| 4 | Global Payments | 25.34 Bn | 19.93 Bn | 2.03 Bn | 63.57 Bn |
| 5 | Rb Global | 16.15 Bn | 15.62 Bn | 935.50 Mn | 12.49 Bn |
| 6 | Aramark | 15.72 Bn | 15.22 Bn | 430.34 Mn | 13.97 Bn |
| 7 | UL Solutions | 15.16 Bn | 14.72 Bn | 417.00 Mn | 3.12 Bn |
| 8 | Rentokil Initial | 11.92 Bn | 9.40 Bn | - | - |
| 9 | Dolby Laboratories | 6.14 Bn | 5.47 Bn | 264.68 Mn | 3.16 Bn |
| 10 | Cimpress | 2.14 Bn | 1.89 Bn | 429.99 Mn | 2.20 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.20 Bn |
| Mar 31, 2026 | 2.05 Bn |
| Dec 31, 2025 | 2.09 Bn |
| Sep 30, 2025 | 1.97 Bn |
| Jun 30, 2025 | 1.97 Bn |
| Mar 31, 2025 | 1.88 Bn |
| Dec 31, 2024 | 1.92 Bn |
| Sep 30, 2024 | 1.88 Bn |
| Jun 30, 2024 | 1.89 Bn |
| Mar 31, 2024 | 1.78 Bn |
| Dec 31, 2023 | 1.95 Bn |
| Sep 30, 2023 | 1.81 Bn |
| Jun 30, 2023 | 1.85 Bn |
| Mar 31, 2023 | 1.89 Bn |
| Dec 31, 2022 | 1.95 Bn |
| Sep 30, 2022 | 2.10 Bn |
| Jun 30, 2022 | 2.17 Bn |
| Mar 31, 2022 | 2.12 Bn |
| Dec 31, 2021 | 2.28 Bn |
| Sep 30, 2021 | 2.18 Bn |